The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap

Jonker, Anneliene H.; Tataru, Elena-Alexandra; Graessner, Holm; Dimmock, David; Jaffe, Adam; Baynam, Gareth; Davies, James; Mitkus, Shruti; Iliach, Oxana; Horgan, Rich; Augustine, Erika F.; Bateman-House, Alison; Pasmooij, Anna Maria Gerdina; Yu, Tim; Synofzik, Matthis; Douville, Julie; Lapteva, Larissa; Brooks, Philip John; O'Connor, Daniel; Aartsma-Rus, Annemieke

dc.contributor.author	Graessner, Holm
dc.contributor.author	Synofzik, Matthis
dc.date.accessioned	2025-05-13T08:54:54Z
dc.date.available	2025-05-13T08:54:54Z
dc.date.issued	2025
dc.identifier.issn	1474-1776
dc.identifier.uri	http://hdl.handle.net/10900/165491
dc.language.iso	en	de_DE
dc.publisher	Berlin : Nature Portfolio	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41573-024-01059-3	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250203000000_00576
utue.publikation.seiten	40-56	de_DE
utue.personen.roh	Jonker, Anneliene H.
utue.personen.roh	Tataru, Elena-Alexandra
utue.personen.roh	Graessner, Holm
utue.personen.roh	Dimmock, David
utue.personen.roh	Jaffe, Adam
utue.personen.roh	Baynam, Gareth
utue.personen.roh	Davies, James
utue.personen.roh	Mitkus, Shruti
utue.personen.roh	Iliach, Oxana
utue.personen.roh	Horgan, Rich
utue.personen.roh	Augustine, Erika F.
utue.personen.roh	Bateman-House, Alison
utue.personen.roh	Pasmooij, Anna Maria Gerdina
utue.personen.roh	Yu, Tim
utue.personen.roh	Synofzik, Matthis
utue.personen.roh	Douville, Julie
utue.personen.roh	Lapteva, Larissa
utue.personen.roh	Brooks, Philip John
utue.personen.roh	O'Connor, Daniel
utue.personen.roh	Aartsma-Rus, Annemieke
dcterms.isPartOf.ZSTitelID	Nature Reviews Drug Discovery	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	24	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE